Buscar
Mostrando ítems 1-1 de 1
Diastolic dysfunction following anthracycline-based chemotherapy in breast cancer patients: incidence and predictors
(AlphaMed Press, 2015-07-16)
[Abstract] INTRODUCTION:
Cardiotoxicity represents a major limitation for the use of anthracyclines or trastuzumab in breast cancer patients. Data from longitudinal studies of diastolic dysfunction (DD) in this group ...